PETS · NASDAQ · Specialty Retail

PetMed Express (PETS)

Supplies pet medicines and health products directly while extending its pharmacy platform to retail partners.

$1.58
vs last close−0.02 (−1.25%)
Loading prices…

PetMed Express, Inc.PETS
Consumer Discretionary

PetMeds and PetCareRx sell prescription and non-prescription medicines, food, supplements, supplies, and related pet-health services for dogs, cats, and horses. Direct fulfillment, recurring-order programs, and a white-label retailer arrangement combine consumer e-commerce with licensed-pharmacy infrastructure.

Prescription and non-prescription medicines, food, supplements, supplies, and related pet-health services are sold through the PetMeds and PetCareRx brands for dogs, cats, and horses. Products ship directly to customers through the company's one reportable segment.

Prescription fulfillment requires veterinarian authorization and relies on pharmacy operations licensed in all 50 states. AutoShip and membership programs support recurring orders, while the Rural King agreement brings pharmacy, pharmacist, and e-commerce capabilities to a retailer's channels.

The business depends on its regulated prescription-fulfillment model, continued competitive execution in e-commerce pet pharmacy, and execution of its cost-reduction plan.

Company facts

CEOLeslie C.G. Campbell
ListedApr 26, 1999
ExchangeNASDAQ
HeadquartersDelray Beach, FL
CountryUnited States
Employees189
CIK0001040130
ISINUS7163821066

Market cap$34.2M
EPS (ttm)−$1.38
P/E (ttm)−1.16
ROE-91.7%
P/B1.49
P/S0.2025
Dividend yieldDiv yield
Beta1.30vs XLY 0.16

Price target$7.00+337.5%Average of 10 analysts
ConsensusHold6 of 10 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

No analyst notes in the last 24 months.

Next report
Oct 13, 26
in 21 days
EPS estimate
−$0.06
Revenue estimate
$62.0M
Fiscal quarter
Q2 FY27

EPSReportedEstimate

Feb '25Aug '25Sep '25Dec '25Feb '26Jun '26Aug '26Oct '26
Reported−$0.03−$0.49−$0.07−$0.34−$0.50−$0.19−$0.28Pending
Estimate$0.01−$0.06−$0.06−$0.02−$0.06−$0.18$0.12−$0.06
Surprise−700.0%−716.7%−16.7%−1,600.0%−733.3%−5.6%−333.3%

RevenueReportedEstimate

Feb '25Aug '25Sep '25Dec '25Feb '26Jun '26Aug '26Oct '26
Reported$53.0M$51.1M$51.2M$44.4M$40.7M$42.8M$41.0MPending
Estimate$54.0M$69.3M$69.3M$69.3M$54.0M$52.0M$71.0M$62.0M
Surprise−1.9%−26.3%−26.2%−36.0%−24.8%−17.7%−42.2%
Estimate−$0.06
ReportedDue Oct 13, 2026
Estimate$62.0M
ReportedDue Oct 13, 2026
View details

Debt to equity1.80%
Current ratio68.00%

ProfitabilityRevenueNet incomeNet margin

Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue$59.6M$53.0M$46.5M$51.2M$44.4M$40.7M$42.8M$41.0M
Net income$2.3M−$707.0K−$11.6M−$34.2M−$8.5M−$10.6M−$4.1M−$6.1M
Net margin3.9%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

GrowthOperating income

Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Operating income$554.0K−$450.0K−$6.0M−$6.9M−$8.4M−$10.5M−$5.7M−$6.2M
YoY growth−36.7%Loss narrowedLoss widenedTurned lossTurned lossLoss widenedLoss narrowedLoss narrowed

Balance sheet, Jun 30, 2026Cash & short-term investments $13.1M · Total debt $414.0K · Total assets $63.8M · Shareholders' equity $23.0M

Revenue
$41.0M
Operating income
−$6.2M
Net income
−$6.1M
View details

Dividend yield
Next ex-date
Annual dividend
Schedule

HistoryDividendAnnual yield

Nov '21Feb '22May '22Aug '22Nov '22Feb '23Jun '23Aug '23
Dividend$0.30$0.30$0.30$0.30$0.30$0.30$0.30$0.30
Annual yield3.85%4.97%5.94%5.39%6.26%6.05%8.18%9.40%
Ex-dateNov 5Feb 4May 19Aug 11Nov 17Feb 16Jun 5Aug 11
Payment dateNov 19Feb 18May 27Aug 19Nov 30Feb 27Jun 12Aug 18
View details

Institutions21.75%4.72M shares
51 holders · as of Jun 30, 2026
Insiders17.15%3.72M shares
12 holders · as of Sep 21, 2026
Strategic holders29.92%6.49M shares
3 holders · as of Jun 9, 2026
Other31.18%6.76M shares
remainder

21.68M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Nina Capital Holdings Inc.Strategic10 percent owner
11.99%2.60Mfiled Jun 9, 2026
Silvercape Investments LtdStrategic10 percent owner
11.90%2.58Mfiled Aug 14, 2025
Moises Tache GalanteInsider
9.59%2.08Mfiled Oct 10, 2024
Epoch Investment Partners, Inc.Strategic
6.03%1.31Mfiled Feb 8, 2019
Renaissance Technologies LLCInstitution
5.22%1.13Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Jun 8, 2026Nina Capital Holdings Inc.10 percent owner+25,000$1.75
View details

  • Chewy

    Online pet pharmacy and Autoship overlap across medicines and supplies

  • Petco

    Pet-specialty retail and veterinary pharmacy across supplies and prescriptions

  • Walmart

    Pet pharmacy delivery and omnichannel care overlap in prescriptions and supplies

Compare

CompanyPriceChange
PetMed Express$1.58−1.25%$34.2M0.2−19.9%
Chewy$20.37−0.68%$8.49B39.418.10.7+7.3%
Petco$2.42+1.90%$676.8M23.710.30.1+0.1%
Walmart$109.05+1.50%$855.02B38.836.41.2+5.9%
Median38.818.10.7+5.9%